Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Milestone Pharmaceuticals...

    NASDAQ: MIST · Real-Time Price · USD
    1.86
    -0.08 (-4.12%)
    At close: Jun 27, 2025, 3:59 PM
    1.96
    5.09%
    After-hours: Jun 27, 2025, 04:49 PM EDT

    Milestone Pharmaceuticals Statistics

    Share Statistics

    Milestone Pharmaceuticals has 53.46M shares outstanding. The number of shares has increased by 0.18% in one year.

    Shares Outstanding

    n/a
    		 53.46M

    Shares Change (YoY)

    n/a
    		 0.18%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 37.09%

    Shares Floating

    n/a
    		 52.9M

    Failed to Deliver (FTD) Shares

    n/a
    		 16,844

    FTD / Avg. Volume

    n/a
    		 0.86%

    Short Selling Information

    The latest short interest is 2.12M, so 3.96% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.12M

    Short % of Shares Out

    n/a
    		 3.96%

    Short % of Float

    n/a
    		 3.96%

    Short Ratio (days to cover)

    n/a
    		 2.46

    Valuation Ratios

    The PE ratio is -3.54 and the forward PE ratio is -2.2. Milestone Pharmaceuticals's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -3.54

    Forward PE

    n/a
    		 -2.2

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 11.17

    P/FCF Ratio

    n/a
    		 -5.08

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Milestone Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.1, with a Debt / Equity ratio of 4.17.

    Current Ratio

    n/a
    		 9.1

    Quick Ratio

    n/a
    		 9.1

    Debt / Equity

    n/a
    		 4.17

    Debt / EBITDA

    n/a
    		 -1.3

    Debt / FCF

    n/a
    		 -1.9

    Interest Coverage

    n/a
    		 11.76

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,258,151.52

    Employee Count

    n/a
    		 33

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -259K

    Effective Tax Rate

    n/a
    		 0.62%

    Stock Price Statistics

    The stock price has increased by 51.16% in the last 52 weeks. The beta is 0.92, so Milestone Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.92

    52-Week Price Change

    n/a
    		 51.16%

    50-Day Moving Average

    n/a
    		 1.43

    200-Day Moving Average

    n/a
    		 1.66

    Relative Strength Index (RSI)

    n/a
    		 72.22

    Average Volume (20 Days)

    n/a
    		 1,955,530

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -42.1M

    Net Income

    n/a
    		 -41.52M

    EBITDA

    n/a
    		 -42.1M

    EBIT

    n/a
    		 -38.2M

    Earnings Per Share (EPS)

    n/a
    		 -0.67
    Full Income Statement

    Balance Sheet

    The company has 25.31M in cash and 54.8M in debt, giving a net cash position of -29.48M.

    Cash & Cash Equivalents

    n/a
    		 25.31M

    Total Debt

    n/a
    		 54.8M

    Net Cash

    n/a
    		 -29.48M

    Retained Earnings

    n/a
    		 -367.55M

    Total Assets

    n/a
    		 61.88M

    Working Capital

    n/a
    		 47.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.85M and capital expenditures -33K, giving a free cash flow of -28.88M.

    Operating Cash Flow

    n/a
    		 -28.85M

    Capital Expenditures

    n/a
    		 -33K

    Free Cash Flow

    n/a
    		 -28.88M

    FCF Per Share

    n/a
    		 -0.46
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MIST does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MIST is $7, which is 259% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 259%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.8

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist